Manufacturer
PHARMANIAGA MANUFACTURING BERHAD
Contents
Salbutamol sulfate
Indication
Acute bronchospasm
Instruction
Adult: 2-4 mg 3 or 4 times daily, up to 8 mg 3 or 4 times daily as required in some patients. As modified-release tab: 8 mg bid.
Child: 2-6 yr 1-2 mg; >6-12 yr 2 mg; >12 yr Same as adult dose. Doses to be given 3 or 4 times daily.
Elderly: 2 mg 3 or 4 times daily.
Drug interaction
Increased risk of hypokalaemia w/ K depleting agents (e.g. corticosteroid, diuretics, xanthines, digoxin). Increased uterine inertia w/ halogenated anaesth (IV). Increased risk of pulmonary oedema w/ corticosteroids. May antagonise the effect of anti-diabetics. Effects may be altered by guanethidine, reserpine, methyldopa, TCAs and MAOIs. Increased risk of CV effects w/ other sympathomimetic agents. Antagonistic effect w/ β-blockers.
Malaysia
